Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Wilson disease.

Reinhard Kitzberger1, Christian Madl, Peter Ferenci

  • 1Department of Internal Medicine IV, Gastroenterology and Hepatology, Medical University of Vienna, Währinger Gürtel 18-20, A 1090, Vienna, Austria.

Metabolic Brain Disease
|December 31, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Corrigendum to "Improved clinical outcomes of patients with cirrhosis and acute variceal bleeding over the last 2 decades." Gastrointest Endosc 2025;102:733-7.

Gastrointestinal endoscopy·2026
Same author

The Link of Portal-Hypertensive Gastropathy to Anaemia, Systemic Inflammation and Disease Progression in Cirrhosis.

Liver international : official journal of the International Association for the Study of the Liver·2026
Same author

Response-guided bulevirtide ± pegylated interferon alfa-2a: Long-term outcomes observed in the nationwide Austrian hepatitis D cohort study.

JHEP reports : innovation in hepatology·2026
Same author

Letter: Post-Banding Ulcer Bleeding Is More Common With Urgent EBL and Renal Dysfunction.

Alimentary pharmacology & therapeutics·2026
Same author

Improved clinical outcomes of patients with cirrhosis and acute variceal bleeding over the last 2 decades.

Gastrointestinal endoscopy·2025
Same author

A systematic PCR record-based re-call of HCV-RNA-positive people enables re-linkage to care and HCV elimination in Austria - The ELIMINATE project.

Liver international : official journal of the International Association for the Study of the Liver·2024
Same journal

Crocin alleviates "short-term" Cadmium-induced brain and lung toxicities: investigation of key neuropeptides GLP-1 and spexin as biomarkers.

Metabolic brain disease·2026
Same journal

Electroacupuncture-modulated DHCR24 facilitates spinal cord injury recovery by attenuating apoptosis and neuroinflammation via the Wnt signaling pathway.

Metabolic brain disease·2026
Same journal

Supra-additive neuroprotective effects of berberine-metformin combination in diabetic encephalopathy: Chou-Talalay synergy quantification, AMPK-Nrf2 axis modulation, and pharmacokinetic verification.

Metabolic brain disease·2026
Same journal

The protective role of melatonin on the brain in a rat model of Alzheimer's disease.

Metabolic brain disease·2026
Same journal

Neuroprotective effects of 2-(2-nitrophenyl)-1,3-thiazolidine-4-carboxylic acid in a rotenone-induced Parkinson's disease rat model: Modulation of oxidative stress, behavioral dysfunction, and iron accumulation.

Metabolic brain disease·2026
Same journal

Gestational deltamethrin exposure exacerbates post-traumatic epileptiform activity and social deficits, diminishing the therapeutic efficacy of curcumin in rats.

Metabolic brain disease·2026
See all related articles

Wilson disease is an inherited copper metabolism disorder causing toxic copper buildup. Early treatment with chelators can reverse liver and neurological symptoms, improving patient outcomes.

Area of Science:

  • Neurobiology
  • Genetics
  • Metabolic Disorders

Background:

  • Wilson disease (WD) is an autosomal recessive inherited disorder of copper metabolism.
  • Pathological copper accumulation occurs in organs like the liver and brain.
  • Key features include liver disease, neurological symptoms, and Kayser-Fleischer corneal rings.

Purpose of the Study:

  • To summarize the understanding of Wilson disease pathogenesis and clinical manifestations.
  • To highlight the role of copper and ATP7B in both hepatic and central nervous system functions.
  • To discuss the implications of copper dysregulation in neurodegenerative processes.

Main Methods:

  • Review of existing literature on Wilson disease.
  • Analysis of clinical presentations, including neurological and hepatic symptoms.

Related Experiment Videos

  • Examination of genetic factors (ATP7B gene) and molecular mechanisms of copper transport.
  • Discussion of neuroimaging (MRI) and electrophysiological findings.
  • Exploration of the role of copper-binding proteins (APP, Prion protein, SOD1) in neurobiology.

    • Main Results:

    • Wilson disease is characterized by impaired copper trafficking in hepatocytes due to ATP7B gene defects.
    • Neurological symptoms, such as ataxia and Parkinsonian signs, are common and linked to basal ganglia changes.
    • Copper accumulation affects neuronal function, potentially through altered copper-containing enzymes and oxidative stress.
    • Evidence suggests a link between copper dysregulation and neurodegenerative proteins like APP and Prion.
    • Treatment with zinc or copper chelators can reverse symptoms and MRI abnormalities.

    Conclusions:

    • Wilson disease results from a genetic defect in copper metabolism, impacting multiple organs.
    • The central nervous system is significantly affected, with potential links to broader neurodegenerative mechanisms.
    • Effective treatments exist, emphasizing the importance of early diagnosis and management.
    • Further research into copper's role in neurobiology is warranted.